🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Investigational Drug Acquiring Traction Online

Retatrutide, which remains in research studies, is being promoted by online personalities for its alleged fat-burning effects. Viewers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and claims of next-day British shipping. Vendors market the substance there before directing buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to users administering products of uncertain source.

Several experts stated the popularity for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate medicines, marketing, and customer regulations, risking fines, prosecution or prison.

Platform Reaction and Content Elimination

According to the social media company, the service has removed violative material and banned related keywords and query recommendations. The company stated it was dedicated to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Online Trading Activities

Investigations also found communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, filled with photos of slimming results, positive reviews and detailed instructions for preparing or injecting at residence.

After minutes of joining one community, a vendor shared WhatsApp details, where most transactions take place. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about body mass, health issues or previous experience.

Product Information and Pricing

Inside these groups, messages show dark colored parcels with postal service labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled pens usually priced at £160 for 20 milligrams. When questioned how much time a pen should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service said it actively moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they cannot confirm. Although the science behind this drug is sound, these digital versions may not include what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her team has previously encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet authorized … may subject users to potentially serious health risks”.